Rafferty Asset Management
EDIT icon

Rafferty Asset Management’s Editas Medicine EDIT Stock Holding History

Rafferty Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-214,892
Closed -$1M – 1157
2024
Q2 		$1M Sell
214,892
-638,222
-75% -$3.6M ﹤0.01% 819
2024
Q1 		$6.33M Buy
853,114
+444,049
+109% +$3.69M 0.02% 413
2023
Q4 		$4.14M Sell
409,065
-152,799
-27% -$1.34M 0.02% 487
2023
Q3 		$4.38M Sell
561,864
-80,327
-13% -$689K 0.03% 414
2023
Q2 		$5.29M Sell
642,191
-42,161
-6% -$367K 0.03% 400
2023
Q1 		$4.96M Sell
684,352
-86,600
-11% -$770K 0.03% 386
2022
Q4 		$6.84M Buy
770,952
+333,191
+76% +$3.66M 0.06% 307
2022
Q3 		$5.36M Buy
437,761
+94,662
+28% +$1.47M 0.06% 324
2022
Q2 		$4.06M Sell
343,099
-11,964
-3% -$160K 0.04% 322
2022
Q1 		$6.75M Buy
355,063
+173,292
+95% +$3.22M 0.04% 285
2021
Q4 		$4.83M Buy
181,771
+134,623
+286% +$4.63M 0.03% 398
2021
Q3 		$1.94M Sell
47,148
-22,560
-32% -$1.24M 0.01% 644
2021
Q2 		$3.95M Sell
69,708
-2,282
-3% -$84.3K 0.02% 400
2021
Q1 		$3.02M Buy
71,990
+56,935
+378% +$3.24M 0.02% 488
2020
Q4 		$1.06M Sell
15,055
-51,104
-77% -$2.1M 0.01% 483
2020
Q3 		$1.86M Buy
66,159
+32,685
+98% +$1.06M 0.02% 441
2020
Q2 		$990K Buy
+33,474
New +$875K 0.01% 546
2020
Q1 		– Sell
-49,263
Closed -$1.46M – 659
2019
Q4 		$1.46M Sell
49,263
-65,902
-57% -$1.65M 0.02% 461
2019
Q3 		$2.62M Sell
115,165
-31,188
-21% -$773K 0.04% 261
2019
Q2 		$3.62M Buy
146,353
+5,432
+4% +$130K 0.06% 228
2019
Q1 		$3.45M Buy
+140,921
New +$3.19M 0.06% 192

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rafferty Asset Management's EDIT Position: Q3 2024 in Review

Rafferty Asset Management sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 214,892 shares — an estimated $1M sold.

Rafferty Asset Management first reported a position in EDIT in Q1 2019 and held it in 21 quarters. The position peaked at $6.84M in Q4 2022. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

  • Rafferty Asset Management reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
  • Rafferty Asset Management sold 214,892 Editas Medicine shares in Q3 2024, an estimated $1M.
  • Rafferty Asset Management first reported a position in Editas Medicine in Q1 2019 and held it in 21 quarters.
  • Rafferty Asset Management's Editas Medicine position peaked at $6.84M in Q4 2022.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on Rafferty Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.